WELLINGTON MANAGEMENT GROUP LLP - PHASEBIO PHARMACEUTICALS INC ownership

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 59 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$2,210,000
-70.5%
1,674,690
-41.6%
0.00%
-100.0%
Q4 2021$7,490,000
-40.2%
2,869,650
-28.7%
0.00%
-50.0%
Q3 2021$12,517,000
-25.9%
4,024,658
-11.3%
0.00%
-33.3%
Q2 2021$16,889,000
+2.3%
4,539,897
-4.9%
0.00%0.0%
Q1 2021$16,513,000
+213.5%
4,772,918
+204.5%
0.00%
+200.0%
Q4 2020$5,268,000
-54.9%
1,567,656
-52.9%
0.00%
-50.0%
Q3 2020$11,686,000
-36.7%
3,329,262
-17.1%
0.00%
-50.0%
Q2 2020$18,474,000
+38.6%
4,016,229
-0.3%
0.00%0.0%
Q1 2020$13,330,000
-43.9%
4,027,284
+3.5%
0.00%
-20.0%
Q4 2019$23,782,000
+45.8%
3,892,256
-0.5%
0.01%
+25.0%
Q3 2019$16,316,000
-68.1%
3,912,727
+0.4%
0.00%
-63.6%
Q2 2019$51,105,000
+56.7%
3,895,213
+13.6%
0.01%
+57.1%
Q1 2019$32,617,000
+213.1%
3,429,779
+1.7%
0.01%
+133.3%
Q4 2018$10,416,0003,370,9600.00%
Other shareholders
PHASEBIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 1,607,044$5,400,0000.70%
NEA Management Company, LLC 6,643,704$22,323,0000.59%
DAFNA Capital Management LLC 320,542$1,077,0000.32%
Platform Technology Partners 141,025$474,0000.23%
Parkman Healthcare Partners LLC 110,547$371,0000.10%
Rock Springs Capital Management LP 1,314,374$4,416,0000.09%
GSA CAPITAL PARTNERS LLP 140,341$472,0000.08%
SABBY MANAGEMENT, LLC 65,000$218,0000.04%
Virtu Financial LLC 28,821$97,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 127,600$429,0000.01%
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders